MedDevNews, Q3 2023
Q3 showed a continued decrease in the number of OEM transactions, while a few larger transactions brought up the overall transaction value. Enovis was particularly active in M&A, making or announcing four other acquisitions so far this year.
This quarter, England closed the sale of SEAL to Enovis, representing our 11th transaction in orthopedics and 18th in Medtech more broadly. Read the full report here.